|
|
Volumn 59, Issue 10, 2013, Pages 1447-1456
|
|
Companion biomarkers: paving the pathway to personalized treatment for cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
B RAF KINASE;
BIOLOGICAL MARKER;
BRAF PROTEIN, HUMAN;
EML4-ALK FUSION PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
ESTROGEN RECEPTOR;
KRAS PROTEIN, HUMAN;
ONCOPROTEIN;
RAS PROTEIN;
ANTAGONISTS AND INHIBITORS;
GENE TRANSLOCATION;
GENETICS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PERSONALIZED MEDICINE;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BIOLOGICAL MARKERS;
HUMANS;
INDIVIDUALIZED MEDICINE;
MOLECULAR TARGETED THERAPY;
MUTATION;
NEOPLASMS;
ONCOGENE PROTEINS, FUSION;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS B-RAF;
RAS PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
TRANSLOCATION, GENETIC;
|
|
EID: 84890281763
PISSN: None
EISSN: 15308561
Source Type: Journal
DOI: 10.1373/clinchem.2012.200477 Document Type: Review |
|
Times cited : (42)
|
|
References (0)
|
